Through interdisciplinary research, community engagement, and data-driven strategies, the new Climate and Health Research Initiative (CHeRI) will unite efforts across Duke and advance efforts in the Duke University School of Medicine, Duke Global Health Institute, Nicholas School of the Environment, and the Nicholas Institute for Energy, Environment & Sustainability.

Duke research suggests that extremely fast bursts of radiation may have the potential to target cancer cells and boost immune response while sparing healthy tissue.

For most of rural America, access to clinical research addressing rural health is extremely limited. As a leader of a program designed to develop future researchers through hands-on experience and mentorship, Danny Benjamin, MD, PhD, MPH, is working to address this shortage.

Duke research reveals that a decades-old breast cancer vaccine may have unlocked a powerful immune memory response, now supercharged by a new antibody.

Duke Pathology has implemented a new platform in the My Duke Health patient portal that distills complex medical terminology into easy-to-understand plain language explanations and diagrams.

From breast cancer to rare pediatric diseases, federally funded Duke biomedical research has helped Duke staff and faculty and their families.

Doctors are taking a closer look at how obesity affects breast cancer and whether popular weight loss drugs might fit into future breast cancer prevention and treatment strategies.

E. Harvey Estes, Jr., MD, a pioneering physician, educator, and leader whose contributions to Duke have left an enduring legacy, passed away on October 16, 2025, after having celebrated his 100th birthday this past May.   

Researchers at Duke University School of Medicine have identified two enzymes that can produce a key ingredient in antibiotics, antivirals, and cancer drugs without the use of toxic chemicals.

Despite leading the world in health spending, the U.S. lags in preventing premature deaths, performing worse than expected for its wealth.